does semaglutide cause blood in urine Long-term kidney outcomes of obesity and cardiovascular disease in the SELECT trial Ozempic and GLP-1 Drugs: Risk

Annals of the New York Academy of Sciences, 1033(1), 168 Marx, W., Teleni, L., Opie, R., Kelly, J., Marshall, S., Itsiopoulos, C., & Isenring, E

Personalized Support for Managing Nausea When it comes to managing nausea, a personalized approach can make all the difference

What should I do if I experience side effects during a retatrutide trial

Semaglutide delays gastric emptying and commonly causes gastrointestinal effects

Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders